Thursday, August 26, 2021 7:40:29 AM
Sorry for the delay in replying as your message was flagged into the Spam folder. We are going to stay current as we filed our Q2 report today and the next deadline is October 15 for the Q3 report. In the meantime, we are working on the audits to switch back to EDGAR reporting direct to the SEC (versus the current OTC filing). Either method will keep us current but completing the audits will allow us to uplist to OTC QB from PINK which we think will also help attract additional open market investors. We will have forthcoming news related to the acquisitions previously announced.
---
best regards,
Doug
Doug Williams
Xalles Administration
info@xalles.com
Xalles.com
202-595-1299
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM